Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier
Yasutaka Mori1,3,4, Shingo Nakamura2, Satoko Kishimoto1, Mitsuyuki Kawakami4, Satoshi Suzuki4, Takemi Matsui4, Masayuki Ishihara11Research Institute, 2Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan; 3Aeromedical Laboratory, Japan Air Self-Defense Force, Sayama, S...
Guardado en:
Autores principales: | Yasutaka Mori, Shingo Nakamura, Satoko Kishimoto, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd16341a8df241ad99b294d80fed92bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery
por: Yu X, et al.
Publicado: (2016) -
Complexation of CXCL12, FGF-2 and VEGF with Heparin Modulates the Protein Release from Alginate Microbeads
por: Edyta Adrian, et al.
Publicado: (2021) -
Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins.
por: Paula A Ferreira, et al.
Publicado: (2012) -
Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel
por: Kim DH, et al.
Publicado: (2014) -
Sexual selection halts the relaxation of protamine 2 among rodents.
por: Lena Lüke, et al.
Publicado: (2011)